ARI Advisory Committee


The AO Research Institute Davos Advisory Committee gives operational and strategic scientific advice to the AO Research Institute Davos (ARI). This then helps to assure the efficient deployment of the AOF infrastructure with respect to the service provision activities to Clinical Divisions and CPPs (Clinical Priority Programs). The ARI AC monitors the ARI output on behalf of the AO Foundation Board (AOFB) and is a group with multidisciplinary expertise relevant to the R+D objectives of the AO Foundation. It acts as both a sounding board and sparring partner for the Director and scientists of the AO Research Institute Davos. The ARI AC has no funds available for own projects, i.e. no budget authority.

The ARI AC’s tasks and responsibilities in detail are to:

  • Give advice to the AO Research Institute Davos in the fields of:
    • Portfolio of competences (skills of personnel and type of equipment)
    • Strategy and priority setting for direct funds of the AO Research Institute Davos
    • Exploratory research Collaborative Research Program(s)
    • Business development and initial advice on technology transfer
    • Regulatory issues
  • Monitor the ARI output of direct funding on behalf of the AOFB
  • Support the advancement of the capabilities of the AO Research Institute Davos to assure the efficient deployment of the infrastructure

The current ARI Advisory Committee (ARI AC) (since December 2013) is

  • Prof. Dr. Michael Schütz (Chair/ clinician) Charité Center of Musculoskeletal Surgery  Berlin,  Germany
  • Prof. Brian Johnstone Oregon Health & Science University, USA
  • Prof. Joost de Bruijn University of Twente, Netherlands
  • Prof. Robert Frigg – ex Head of Synthes Global Technology and Innovation Group

The chair of the ARI AC represents the ARI AC at the new AO R&D Platform.​